The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies.
Times cited: 73
Trastuzumab-related cardiotoxicity in the elderly: a role for cardiovascular risk factors.
Annals of oncology : official journal of the European Society for Medical Oncology.
Times cited: 66